In summary, our findings provide evidence that the altered AKT/mTOR signaling cascades, increased glycolysis, enhanced de novo lipogenesis and fat uptake, and heightened inflammation, all together contributed to the development of NASH-related HCC in WT mice. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatohepatitis.